TBPH Intrinsic Valuation and Fundamental Analysis - Theravance Biopharma Inc

	Theravance Biopharma Inc NASDAQ:TBPH	KY
	Strandline Resources Ltd ASX:STA	AU
	Boxlight Corp NASDAQ:BOXL	US

Intrinsic Value

The intrinsic value for Theravance Biopharma Inc (TBPH) under the Base Case is 15.977 USD. Compared with the current market price of 17.015 USD, the stock appears Overvalued by 6% .

Intrinsic value calculated using DCF

$15.977

Other reference points

Multiples estimate

$6.886

Wall St target

$18.02

Do our valuations actually work? See backtest results .

TBPH Intrinsic Value

Overvaluation 6%

Intrinsic Value

Price $17.015

Loading...

What is Valuation History?

Track Buy Zone

20% below Intrinsic Value $12.78

Get notified when the price drops into your buy zone

Current Price $17.02

Intrinsic Value $15.98

Margin of Safety 20% $12.78

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations

Let our AI break down the key assumptions behind the intrinsic value calculation for Theravance Biopharma Inc.

Explain Valuation